NCT01127906 - Study To Assess The Effect Of PF-04531083 On Heat Pain In Healthy Volunteers With Ultraviolet Light Sensitized Skin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Healthy

Interventions

DRUG

PF-04531083 100mg

Oral PF-04531083 100mg suspension single dose

DRUG

PF-04531083 2000mg

Oral PF-04531083 2000mg suspension single dose

DRUG

Placebo suspension

Oral Placebo suspension (matched to PF-04531083 suspension)

DRUG

Placebo tablet

Oral Placebo tablet (matched to Oxycodone)

DRUG

Oxycodone 20mg

Oral Oxycodone 20mg (Oxycontin) controlled release formulation

Trial Locations (1)

Pfizer Investigational Site, Brussels